Both parameters were not significantly increased in MM samples when compared to other tumor types (Figure S3A,B), hence neither of these parameters could explain the higher antitumor-reactivity of CD8+ TILs observed in MM. The gene discussed is CD8A; the disease is Miyoshi myopathy.